SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-23-001483
Filing Date
2023-01-10
Accepted
2023-01-10 17:00:18
Documents
2
Period of Report
2023-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2702
2 EX-24 DOCUMENT attachment1.htm EX-24 4557
  Complete submission text file 0000899243-23-001483.txt   8749
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Issuer) CIK: 0001521036 (see all company filings)

IRS No.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O LANTHEUS HOLDINGS, INC. 201 BURLINGTON RD, SOUTH BUILDING BEDFORD MA 01730
Business Address
Provost Jean-Claude (Reporting) CIK: 0001960060 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36569 | Film No.: 23521765